A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

Merus has reported a 79% 12-month survival rate in cancer patients on its bispecific antibody, cementing William Blair ...

CEL-SCI Corporation ("CEL-SCI" or the "Company") , a clinical stage cancer immunotherapy company, today announced the closing of its underwritten public offering of 2,000,000 shares of its common ...

If I were a producer on a daytime TV show, the type that women watch in their millions, there's only one issue I'd be ...

Months after revealing she was undergoing chemotherapy, 90 Day Fiancé star Liz Woods confirmed that she was diagnosed with ...

Tempus AI stock is trading at a nosebleed valuation, and despite the compelling long-term upside, it's not worth investing at ...

The House bill includes SALT cap increases, changes to Medicaid and SNAP and new rules to claim child tax credits.

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than ...

UnitedHealth Group Incorporated (NYSE:UNH)’s UnitedHealthcare, the largest private health insurer in the U.S., is facing unprecedented public and regulatory scrutiny amid mounting patient frustration ...

Yoga instructor Ania Tippkemper designed this gentle yoga flow to help you relax quickly. Try it to unwind at the end of a ...